Join Dr Sanjeev Rana and Dr Katherine Hickman on Wednesday 30th April from 19:00 for a focused, practical session offering clear, evidence-based guidance on when to use FeNO testing to support asthma diagnosis.

After a short break the In Conversation webinar series is back and for October we were joined by Professor Tom Wilkinson, who is the National Respiratory Audit Programme (NRAP) Clinical Lead (among many other things including Professor of Respiratory Medicine at University of Southampton

In this article, the authors provide a pragmatic consensus approach to calculating and interpreting peak expiratory flow rate (PEFR) variability and reversibility from peak flow diary recordings for asthma diagnosis. This guide is intended for healthcare professionals working in primary care.

In this article, the authors review evidence, guidance and current practice to provide a consensus approach to calculating and interpreting peak expiratory flow rate (PEFR) variability and reversibility from peak flow diary recordings for asthma diagnosis.

Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir

In this edition, we focus on COPD and revisit the 2017 PCRS consensus on COPD treatment titled 'Keeping it Simple.' The updated algorithm aligns with the latest GOLD and NICE guidance, and maintains a focus on patient-centred treatment grounded in evidence, medication optimisation, and continuous

Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir

PCRS recognises a need for improvement in the timely diagnosis of people living with chronic breathlessness and generally welcomes the NHS England diagnostic pathway support tool. PCRS has some concerns that a diagnostic algorithm can communicate an oversimplification of diagnosis.

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis. Fractional exhaled Nitric Oxide (FeNO) tests are simple, non-invasive tests to support the diagnosis of asthma.

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis.

To consider how and when we use FeNO testing, we need to go to the definition of asthma. Both BTS/SIGN1 and GINA2 define it as a predominantly inflammatory disorder of the airways with airway hyperresponsiveness and variability in symptoms.

The common chronic respiratory disorders diagnosed in primary care—asthma and chronic obstructive pulmonary disease (COPD)—are both characterised by airway obstruction.

NICE Diagnostic Guidance 12 (DG12); Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath.